Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease have?
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease has 95 citations in the OpenAlex counts ScholarIQ stores.
When was Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease published?
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease has 2018 year in the ScholarIQ index.
What is the open-access status of Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease?
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease has bronze oa status in the ScholarIQ index.
What is the DOI of Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease?
The DOI for Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease is on the source record.
What is the PMID of Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease?
The PMID for Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease is on the source record.
What is the OpenAlex record for Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease?
The OpenAlex for Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease is on the source record.